Myriad Genetics is a leading biopharmaceutical company. Its strategy is to develop novel health care products in areas of critical need and to address some of the most pervasive diseases of the times. It offers a range of cancer predictive medicine products and is developing therapeutics that include drug candidates in the areas of Alzheimer s disease and cancer. Myriad s pharmaceuticals include FLURIZAN, MPC-6827 and MPC-2130. Myriad is ultimately committed to personalized medical care. Myriad Genetics maintains head offices in Salt Lake City.